The global Active Hemostatic Agents market was valued at million in 2024 and is projected to reach US$ million by 2031, at a CAGR of %during the forecast period.
Active hemostatic agents are standard surgical techniques to manage bleeding from surgical surfaces. Active hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools helps in the progress of active hemostats into present-day surgery and urology, and highlight opportunities for future research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Hemostatic Agents manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Active Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Hemostatic Agents. This report contains market size and forecasts of Active Hemostatic Agents in global, including the following market information:
Global Active Hemostatic Agents market revenue, 2020-2025, 2026-2031, ($ millions)
Global Active Hemostatic Agents market sales, 2020-2025, 2026-2031, (K Units)
Global top five Active Hemostatic Agents companies in 2024 (%)
Total Market by Segment:
Global Active Hemostatic Agents market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Active Hemostatic Agents market segment percentages, by Type, 2024 (%)
Thrombin based hemostats
Surgical Sealants
Combination Products
Global Active Hemostatic Agents market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Active Hemostatic Agents market segment percentages, by Application, 2024 (%)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Global Active Hemostatic Agents market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Active Hemostatic Agents market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Hemostatic Agents revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Active Hemostatic Agents revenues share in global market, 2024 (%)
Key companies Active Hemostatic Agents sales in global market, 2020-2025 (estimated), (K Units)
Key companies Active Hemostatic Agents sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic Plc.
Ethicon Inc.
Pfizer Inc.
Baxter International Inc.
CryoLife Inc.
Integra Life Sciences Corporation, etc.
Stryker
Biom’up
BD
Johnson & Johnson Services
C.R.Bard
B. Braun Melsungen AG
Z-Medica LLC
Advanced Medical Solutions Group plc
GELITA GA
Active Hemostatic Agents
Warrior Tactical, LLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Active Hemostatic Agents, market overview.
Chapter 2: Global Active Hemostatic Agents market size in revenue and volume.
Chapter 3: Detailed analysis of Active Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Active Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Active Hemostatic Agents capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Active Hemostatic Agents Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Active Hemostatic Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Hemostatic Agents Overall Market Size
2.1 Global Active Hemostatic Agents Market Size: 2024 VS 2031
2.2 Global Active Hemostatic Agents Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Active Hemostatic Agents Sales: 2020-2031
3 Company Landscape
3.1 Top Active Hemostatic Agents Players in Global Market
3.2 Top Global Active Hemostatic Agents Companies Ranked by Revenue
3.3 Global Active Hemostatic Agents Revenue by Companies
3.4 Global Active Hemostatic Agents Sales by Companies
3.5 Global Active Hemostatic Agents Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Active Hemostatic Agents Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Active Hemostatic Agents Product Type
3.8 Tier 1, Tier 2, and Tier 3 Active Hemostatic Agents Players in Global Market
3.8.1 List of Global Tier 1 Active Hemostatic Agents Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Hemostatic Agents Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Active Hemostatic Agents Market Size Markets, 2024 & 2031
4.1.2 Thrombin based hemostats
4.1.3 Surgical Sealants
4.1.4 Combination Products
4.2 Segment by Type - Global Active Hemostatic Agents Revenue & Forecasts
4.2.1 Segment by Type - Global Active Hemostatic Agents Revenue, 2020-2025
4.2.2 Segment by Type - Global Active Hemostatic Agents Revenue, 2026-2031
4.2.3 Segment by Type - Global Active Hemostatic Agents Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Active Hemostatic Agents Sales & Forecasts
4.3.1 Segment by Type - Global Active Hemostatic Agents Sales, 2020-2025
4.3.2 Segment by Type - Global Active Hemostatic Agents Sales, 2026-2031
4.3.3 Segment by Type - Global Active Hemostatic Agents Sales Market Share, 2020-2031
4.4 Segment by Type - Global Active Hemostatic Agents Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Active Hemostatic Agents Market Size, 2024 & 2031
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Specialty Clinics
5.2 Segment by Application - Global Active Hemostatic Agents Revenue & Forecasts
5.2.1 Segment by Application - Global Active Hemostatic Agents Revenue, 2020-2025
5.2.2 Segment by Application - Global Active Hemostatic Agents Revenue, 2026-2031
5.2.3 Segment by Application - Global Active Hemostatic Agents Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Active Hemostatic Agents Sales & Forecasts
5.3.1 Segment by Application - Global Active Hemostatic Agents Sales, 2020-2025
5.3.2 Segment by Application - Global Active Hemostatic Agents Sales, 2026-2031
5.3.3 Segment by Application - Global Active Hemostatic Agents Sales Market Share, 2020-2031
5.4 Segment by Application - Global Active Hemostatic Agents Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Active Hemostatic Agents Market Size, 2024 & 2031
6.2 By Region - Global Active Hemostatic Agents Revenue & Forecasts
6.2.1 By Region - Global Active Hemostatic Agents Revenue, 2020-2025
6.2.2 By Region - Global Active Hemostatic Agents Revenue, 2026-2031
6.2.3 By Region - Global Active Hemostatic Agents Revenue Market Share, 2020-2031
6.3 By Region - Global Active Hemostatic Agents Sales & Forecasts
6.3.1 By Region - Global Active Hemostatic Agents Sales, 2020-2025
6.3.2 By Region - Global Active Hemostatic Agents Sales, 2026-2031
6.3.3 By Region - Global Active Hemostatic Agents Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Active Hemostatic Agents Revenue, 2020-2031
6.4.2 By Country - North America Active Hemostatic Agents Sales, 2020-2031
6.4.3 United States Active Hemostatic Agents Market Size, 2020-2031
6.4.4 Canada Active Hemostatic Agents Market Size, 2020-2031
6.4.5 Mexico Active Hemostatic Agents Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Active Hemostatic Agents Revenue, 2020-2031
6.5.2 By Country - Europe Active Hemostatic Agents Sales, 2020-2031
6.5.3 Germany Active Hemostatic Agents Market Size, 2020-2031
6.5.4 France Active Hemostatic Agents Market Size, 2020-2031
6.5.5 U.K. Active Hemostatic Agents Market Size, 2020-2031
6.5.6 Italy Active Hemostatic Agents Market Size, 2020-2031
6.5.7 Russia Active Hemostatic Agents Market Size, 2020-2031
6.5.8 Nordic Countries Active Hemostatic Agents Market Size, 2020-2031
6.5.9 Benelux Active Hemostatic Agents Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Active Hemostatic Agents Revenue, 2020-2031
6.6.2 By Region - Asia Active Hemostatic Agents Sales, 2020-2031
6.6.3 China Active Hemostatic Agents Market Size, 2020-2031
6.6.4 Japan Active Hemostatic Agents Market Size, 2020-2031
6.6.5 South Korea Active Hemostatic Agents Market Size, 2020-2031
6.6.6 Southeast Asia Active Hemostatic Agents Market Size, 2020-2031
6.6.7 India Active Hemostatic Agents Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Active Hemostatic Agents Revenue, 2020-2031
6.7.2 By Country - South America Active Hemostatic Agents Sales, 2020-2031
6.7.3 Brazil Active Hemostatic Agents Market Size, 2020-2031
6.7.4 Argentina Active Hemostatic Agents Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Hemostatic Agents Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Active Hemostatic Agents Sales, 2020-2031
6.8.3 Turkey Active Hemostatic Agents Market Size, 2020-2031
6.8.4 Israel Active Hemostatic Agents Market Size, 2020-2031
6.8.5 Saudi Arabia Active Hemostatic Agents Market Size, 2020-2031
6.8.6 UAE Active Hemostatic Agents Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Medtronic Plc.
7.1.1 Medtronic Plc. Company Summary
7.1.2 Medtronic Plc. Business Overview
7.1.3 Medtronic Plc. Active Hemostatic Agents Major Product Offerings
7.1.4 Medtronic Plc. Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.1.5 Medtronic Plc. Key News & Latest Developments
7.2 Ethicon Inc.
7.2.1 Ethicon Inc. Company Summary
7.2.2 Ethicon Inc. Business Overview
7.2.3 Ethicon Inc. Active Hemostatic Agents Major Product Offerings
7.2.4 Ethicon Inc. Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.2.5 Ethicon Inc. Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Active Hemostatic Agents Major Product Offerings
7.3.4 Pfizer Inc. Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Baxter International Inc.
7.4.1 Baxter International Inc. Company Summary
7.4.2 Baxter International Inc. Business Overview
7.4.3 Baxter International Inc. Active Hemostatic Agents Major Product Offerings
7.4.4 Baxter International Inc. Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.4.5 Baxter International Inc. Key News & Latest Developments
7.5 CryoLife Inc.
7.5.1 CryoLife Inc. Company Summary
7.5.2 CryoLife Inc. Business Overview
7.5.3 CryoLife Inc. Active Hemostatic Agents Major Product Offerings
7.5.4 CryoLife Inc. Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.5.5 CryoLife Inc. Key News & Latest Developments
7.6 Integra Life Sciences Corporation, etc.
7.6.1 Integra Life Sciences Corporation, etc. Company Summary
7.6.2 Integra Life Sciences Corporation, etc. Business Overview
7.6.3 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Major Product Offerings
7.6.4 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.6.5 Integra Life Sciences Corporation, etc. Key News & Latest Developments
7.7 Stryker
7.7.1 Stryker Company Summary
7.7.2 Stryker Business Overview
7.7.3 Stryker Active Hemostatic Agents Major Product Offerings
7.7.4 Stryker Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.7.5 Stryker Key News & Latest Developments
7.8 Biom’up
7.8.1 Biom’up Company Summary
7.8.2 Biom’up Business Overview
7.8.3 Biom’up Active Hemostatic Agents Major Product Offerings
7.8.4 Biom’up Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.8.5 Biom’up Key News & Latest Developments
7.9 BD
7.9.1 BD Company Summary
7.9.2 BD Business Overview
7.9.3 BD Active Hemostatic Agents Major Product Offerings
7.9.4 BD Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.9.5 BD Key News & Latest Developments
7.10 Johnson & Johnson Services
7.10.1 Johnson & Johnson Services Company Summary
7.10.2 Johnson & Johnson Services Business Overview
7.10.3 Johnson & Johnson Services Active Hemostatic Agents Major Product Offerings
7.10.4 Johnson & Johnson Services Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.10.5 Johnson & Johnson Services Key News & Latest Developments
7.11 C.R.Bard
7.11.1 C.R.Bard Company Summary
7.11.2 C.R.Bard Business Overview
7.11.3 C.R.Bard Active Hemostatic Agents Major Product Offerings
7.11.4 C.R.Bard Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.11.5 C.R.Bard Key News & Latest Developments
7.12 B. Braun Melsungen AG
7.12.1 B. Braun Melsungen AG Company Summary
7.12.2 B. Braun Melsungen AG Business Overview
7.12.3 B. Braun Melsungen AG Active Hemostatic Agents Major Product Offerings
7.12.4 B. Braun Melsungen AG Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.12.5 B. Braun Melsungen AG Key News & Latest Developments
7.13 Z-Medica LLC
7.13.1 Z-Medica LLC Company Summary
7.13.2 Z-Medica LLC Business Overview
7.13.3 Z-Medica LLC Active Hemostatic Agents Major Product Offerings
7.13.4 Z-Medica LLC Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.13.5 Z-Medica LLC Key News & Latest Developments
7.14 Advanced Medical Solutions Group plc
7.14.1 Advanced Medical Solutions Group plc Company Summary
7.14.2 Advanced Medical Solutions Group plc Business Overview
7.14.3 Advanced Medical Solutions Group plc Active Hemostatic Agents Major Product Offerings
7.14.4 Advanced Medical Solutions Group plc Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.14.5 Advanced Medical Solutions Group plc Key News & Latest Developments
7.15 GELITA GA
7.15.1 GELITA GA Company Summary
7.15.2 GELITA GA Business Overview
7.15.3 GELITA GA Active Hemostatic Agents Major Product Offerings
7.15.4 GELITA GA Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.15.5 GELITA GA Key News & Latest Developments
7.16 Active Hemostatic Agents
7.16.1 Active Hemostatic Agents Company Summary
7.16.2 Active Hemostatic Agents Business Overview
7.16.3 Active Hemostatic Agents Active Hemostatic Agents Major Product Offerings
7.16.4 Active Hemostatic Agents Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.16.5 Active Hemostatic Agents Key News & Latest Developments
7.17 Warrior Tactical, LLC
7.17.1 Warrior Tactical, LLC Company Summary
7.17.2 Warrior Tactical, LLC Business Overview
7.17.3 Warrior Tactical, LLC Active Hemostatic Agents Major Product Offerings
7.17.4 Warrior Tactical, LLC Active Hemostatic Agents Sales and Revenue in Global (2020-2025)
7.17.5 Warrior Tactical, LLC Key News & Latest Developments
8 Global Active Hemostatic Agents Production Capacity, Analysis
8.1 Global Active Hemostatic Agents Production Capacity, 2020-2031
8.2 Active Hemostatic Agents Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Hemostatic Agents Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Active Hemostatic Agents Supply Chain Analysis
10.1 Active Hemostatic Agents Industry Value Chain
10.2 Active Hemostatic Agents Upstream Market
10.3 Active Hemostatic Agents Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Hemostatic Agents Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Active Hemostatic Agents in Global Market
Table 2. Top Active Hemostatic Agents Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Active Hemostatic Agents Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Active Hemostatic Agents Revenue Share by Companies, 2020-2025
Table 5. Global Active Hemostatic Agents Sales by Companies, (K Units), 2020-2025
Table 6. Global Active Hemostatic Agents Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Active Hemostatic Agents Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Active Hemostatic Agents Product Type
Table 9. List of Global Tier 1 Active Hemostatic Agents Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Hemostatic Agents Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Active Hemostatic Agents Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Active Hemostatic Agents Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Active Hemostatic Agents Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Active Hemostatic Agents Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Active Hemostatic Agents Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Active Hemostatic Agents Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Active Hemostatic Agents Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Active Hemostatic Agents Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Active Hemostatic Agents Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Active Hemostatic Agents Sales, (K Units), 2026-2031
Table 21. By Region – Global Active Hemostatic Agents Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Active Hemostatic Agents Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Active Hemostatic Agents Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Active Hemostatic Agents Sales, (K Units), 2020-2025
Table 25. By Region - Global Active Hemostatic Agents Sales, (K Units), 2026-2031
Table 26. By Country - North America Active Hemostatic Agents Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Active Hemostatic Agents Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Active Hemostatic Agents Sales, (K Units), 2020-2025
Table 29. By Country - North America Active Hemostatic Agents Sales, (K Units), 2026-2031
Table 30. By Country - Europe Active Hemostatic Agents Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Active Hemostatic Agents Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Active Hemostatic Agents Sales, (K Units), 2020-2025
Table 33. By Country - Europe Active Hemostatic Agents Sales, (K Units), 2026-2031
Table 34. By Region - Asia Active Hemostatic Agents Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Active Hemostatic Agents Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Active Hemostatic Agents Sales, (K Units), 2020-2025
Table 37. By Region - Asia Active Hemostatic Agents Sales, (K Units), 2026-2031
Table 38. By Country - South America Active Hemostatic Agents Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Active Hemostatic Agents Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Active Hemostatic Agents Sales, (K Units), 2020-2025
Table 41. By Country - South America Active Hemostatic Agents Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Active Hemostatic Agents Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Active Hemostatic Agents Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Active Hemostatic Agents Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Active Hemostatic Agents Sales, (K Units), 2026-2031
Table 46. Medtronic Plc. Company Summary
Table 47. Medtronic Plc. Active Hemostatic Agents Product Offerings
Table 48. Medtronic Plc. Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Medtronic Plc. Key News & Latest Developments
Table 50. Ethicon Inc. Company Summary
Table 51. Ethicon Inc. Active Hemostatic Agents Product Offerings
Table 52. Ethicon Inc. Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Ethicon Inc. Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Active Hemostatic Agents Product Offerings
Table 56. Pfizer Inc. Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. Baxter International Inc. Company Summary
Table 59. Baxter International Inc. Active Hemostatic Agents Product Offerings
Table 60. Baxter International Inc. Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Baxter International Inc. Key News & Latest Developments
Table 62. CryoLife Inc. Company Summary
Table 63. CryoLife Inc. Active Hemostatic Agents Product Offerings
Table 64. CryoLife Inc. Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. CryoLife Inc. Key News & Latest Developments
Table 66. Integra Life Sciences Corporation, etc. Company Summary
Table 67. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product Offerings
Table 68. Integra Life Sciences Corporation, etc. Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Integra Life Sciences Corporation, etc. Key News & Latest Developments
Table 70. Stryker Company Summary
Table 71. Stryker Active Hemostatic Agents Product Offerings
Table 72. Stryker Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Stryker Key News & Latest Developments
Table 74. Biom’up Company Summary
Table 75. Biom’up Active Hemostatic Agents Product Offerings
Table 76. Biom’up Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Biom’up Key News & Latest Developments
Table 78. BD Company Summary
Table 79. BD Active Hemostatic Agents Product Offerings
Table 80. BD Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. BD Key News & Latest Developments
Table 82. Johnson & Johnson Services Company Summary
Table 83. Johnson & Johnson Services Active Hemostatic Agents Product Offerings
Table 84. Johnson & Johnson Services Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Johnson & Johnson Services Key News & Latest Developments
Table 86. C.R.Bard Company Summary
Table 87. C.R.Bard Active Hemostatic Agents Product Offerings
Table 88. C.R.Bard Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. C.R.Bard Key News & Latest Developments
Table 90. B. Braun Melsungen AG Company Summary
Table 91. B. Braun Melsungen AG Active Hemostatic Agents Product Offerings
Table 92. B. Braun Melsungen AG Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. B. Braun Melsungen AG Key News & Latest Developments
Table 94. Z-Medica LLC Company Summary
Table 95. Z-Medica LLC Active Hemostatic Agents Product Offerings
Table 96. Z-Medica LLC Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Z-Medica LLC Key News & Latest Developments
Table 98. Advanced Medical Solutions Group plc Company Summary
Table 99. Advanced Medical Solutions Group plc Active Hemostatic Agents Product Offerings
Table 100. Advanced Medical Solutions Group plc Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Advanced Medical Solutions Group plc Key News & Latest Developments
Table 102. GELITA GA Company Summary
Table 103. GELITA GA Active Hemostatic Agents Product Offerings
Table 104. GELITA GA Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. GELITA GA Key News & Latest Developments
Table 106. Active Hemostatic Agents Company Summary
Table 107. Active Hemostatic Agents Active Hemostatic Agents Product Offerings
Table 108. Active Hemostatic Agents Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Active Hemostatic Agents Key News & Latest Developments
Table 110. Warrior Tactical, LLC Company Summary
Table 111. Warrior Tactical, LLC Active Hemostatic Agents Product Offerings
Table 112. Warrior Tactical, LLC Active Hemostatic Agents Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Warrior Tactical, LLC Key News & Latest Developments
Table 114. Active Hemostatic Agents Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 115. Global Active Hemostatic Agents Capacity Market Share of Key Manufacturers, 2023-2025
Table 116. Global Active Hemostatic Agents Production by Region, 2020-2025 (K Units)
Table 117. Global Active Hemostatic Agents Production by Region, 2026-2031 (K Units)
Table 118. Active Hemostatic Agents Market Opportunities & Trends in Global Market
Table 119. Active Hemostatic Agents Market Drivers in Global Market
Table 120. Active Hemostatic Agents Market Restraints in Global Market
Table 121. Active Hemostatic Agents Raw Materials
Table 122. Active Hemostatic Agents Raw Materials Suppliers in Global Market
Table 123. Typical Active Hemostatic Agents Downstream
Table 124. Active Hemostatic Agents Downstream Clients in Global Market
Table 125. Active Hemostatic Agents Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Active Hemostatic Agents Product Picture
Figure 2. Active Hemostatic Agents Segment by Type in 2024
Figure 3. Active Hemostatic Agents Segment by Application in 2024
Figure 4. Global Active Hemostatic Agents Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Active Hemostatic Agents Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Active Hemostatic Agents Revenue: 2020-2031 (US$, Mn)
Figure 8. Active Hemostatic Agents Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Active Hemostatic Agents Revenue in 2024
Figure 10. Segment by Type – Global Active Hemostatic Agents Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Active Hemostatic Agents Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Active Hemostatic Agents Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Active Hemostatic Agents Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Active Hemostatic Agents Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Active Hemostatic Agents Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Active Hemostatic Agents Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Active Hemostatic Agents Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Active Hemostatic Agents Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Active Hemostatic Agents Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Active Hemostatic Agents Revenue Market Share, 2020-2031
Figure 21. By Region - Global Active Hemostatic Agents Sales Market Share, 2020-2031
Figure 22. By Country - North America Active Hemostatic Agents Revenue Market Share, 2020-2031
Figure 23. By Country - North America Active Hemostatic Agents Sales Market Share, 2020-2031
Figure 24. United States Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Active Hemostatic Agents Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Active Hemostatic Agents Sales Market Share, 2020-2031
Figure 29. Germany Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 30. France Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Active Hemostatic Agents Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Active Hemostatic Agents Sales Market Share, 2020-2031
Figure 38. China Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 42. India Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Active Hemostatic Agents Revenue Market Share, 2020-2031
Figure 44. By Country - South America Active Hemostatic Agents Sales, Market Share, 2020-2031
Figure 45. Brazil Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Active Hemostatic Agents Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Active Hemostatic Agents Sales, Market Share, 2020-2031
Figure 49. Turkey Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Active Hemostatic Agents Revenue, (US$, Mn), 2020-2031
Figure 53. Global Active Hemostatic Agents Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Active Hemostatic Agents by Region, 2024 VS 2031
Figure 55. Active Hemostatic Agents Industry Value Chain
Figure 56. Marketing Channels
